1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole has been researched along with leupeptin in 1 studies
Studies (1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole) | Trials (1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole) | Recent Studies (post-2010) (1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole) | Studies (leupeptin) | Trials (leupeptin) | Recent Studies (post-2010) (leupeptin) |
---|---|---|---|---|---|
13 | 0 | 3 | 944 | 0 | 74 |
Protein | Taxonomy | 1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole (IC50) | leupeptin (IC50) |
---|---|---|---|
Plasminogen | Homo sapiens (human) | 1.2 | |
Cationic trypsin | Bos taurus (cattle) | 8.1 | |
Trypsin | Sus scrofa (pig) | 0.5 | |
Papain | Carica papaya (papaya) | 0.0022 | |
Plasminogen | Bos taurus (cattle) | 3.7 | |
Trypsin-1 | Homo sapiens (human) | 0.6 | |
Trypsin-2 | Homo sapiens (human) | 0.6 | |
Cathepsin B | Bos taurus (cattle) | 0.31 | |
Procathepsin L | Homo sapiens (human) | 0.0045 | |
Cathepsin B | Homo sapiens (human) | 0.0282 | |
Trypsin-3 | Homo sapiens (human) | 0.6 | |
Calpain-1 catalytic subunit | Sus scrofa (pig) | 0.08 | |
Cysteine protease | Leishmania donovani | 0.01 | |
Cysteine proteinase falcipain 2a | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0636 | |
Cysteine protease falcipain-3 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0925 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Raghav, N; Singh, M | 1 |
1 other study(ies) available for 1-acetyl-3,5-diphenyl-4,5-dihydro-(1h)-pyrazole and leupeptin
Article | Year |
---|---|
SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H.
Topics: Animals; Binding Sites; Catalytic Domain; Cathepsin B; Cathepsin H; Chalcones; Cyclization; Humans; Hydrazones; Kinetics; Molecular Docking Simulation; Protease Inhibitors; Protein Binding; Structure-Activity Relationship | 2014 |